Compare FMC Corp (FMC) vs Intel Corp (INTC) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

Intel (INTC) trades at $97.99, down 9.07% on the day, reflecting sector-wide pressure from Micron's China competition concerns. Despite recent earnings beats, the stock shows negative profitability with a net margin of -5.9% and elevated P/E of 904.17. Technical indicators are bearish, with support at $95 and resistance at $107. Positive news includes Jim Cramer's endorsement and ASML's milestone in chipmaking technology, but cash flow trends show heavy investing outflows.

Outlook: Intel faces near-term execution risks in AI competition and PC demand, but analyst consensus targets $107.55 with 37% buy ratings. Key catalysts are Q2 earnings on July 23 and AI adoption progress. Risks include margin pressure and high debt, though liquidity remains strong with $22.1B cash.